BIO - Bio-Rad Laboratories, Inc.Class A -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $9.64B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.77 | 1.19%
Avg Daily Range (30 D): $6.11 | 1.62%
Avg Daily Range (90 D): $6.25 | 1.91%
Institutional Daily Volume
Avg Daily Volume: .12M
Avg Daily Volume (30 D): .2M
Avg Daily Volume (90 D): .22M
Trade Size
Avg Trade Size (Sh.): 46
Avg Trade Size (Sh.) (30 D): 18
Avg Trade Size (Sh.) (90 D): 20
Institutional Trades
Total Institutional Trades: 11,843
Avg Institutional Trade: $4.31M
Avg Institutional Trade (30 D): $5.93M
Avg Institutional Trade (90 D): $5.48M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $9.42M
Avg Closing Trade (30 D): $18.26M
Avg Closing Trade (90 D): $19.1M
Avg Closing Volume: 28.4K
 
News
Oct 6, 2026 @ 8:15 PM
Neogen (NEOG) Q1 Earnings and Revenues Beat Estima...
Source: Na
Oct 6, 2026 @ 8:54 AM
Global Microfluidics Market by Product Type, Appli...
Source: Researchandmarkets.Com
Oct 5, 2026 @ 2:00 PM
Europe Point of Care Diagnostics Market Size and F...
Source: Researchandmarkets.Com
Oct 5, 2026 @ 10:45 AM
Immunogenomics Market Size, Share, Trends, and Gro...
Source: Researchandmarkets.Com
Oct 5, 2026 @ 8:58 AM
Magnetic Beads Market - Global Forecast and Growth...
Source: Researchandmarkets.Com
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $8.23 $13.89 $-19.69
Diluted EPS $8.21 $13.85 $-19.65
Revenue $2.59B $651M $592.1M
Gross Profit $1.34B $345.8M $309.4M
Net Income / Loss $222.4M $371.4M $-527.1M
Operating Income / Loss $53.1M $72.6M $34.1M
Cost of Revenue $1.25B $305.2M $282.7M
Net Cash Flow $164M
PE Ratio    
Splits
Mar 08, 2002 2:1